National Academies of Sciences%2c Engineering%2c and Medicine

Enhancing Biotechnology Innovation and Applications for National Security – Meetings of Experts

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Yahoo Finance

Nanoparticle Applications in Pharma and Biotech: Two-Day Intensive Training Course (Nov 12th - Nov 13th, 2025)

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Training Course (Nov 12th - Nov 13th, 2025)" has been added to ...
Investing News Network on MSN

Biotech and Pharma Market Update: Q3 2025 in Review

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an ...
Mainebiz

Bigelow Lab looks to create 'blue' biotechnology businesses and jobs

Bigelow Laboratory for Ocean Sciences is an East Boothbay nonprofit research institute focused on global ocean health.
Nature

Chitinases And Their Applications In Biotechnology

Chitinases are specialised enzymes that catalyse the degradation of chitin, one of the most abundant natural polysaccharides. Found across diverse biological domains, these enzymes play crucial roles ...
Nasdaq

Krystal Biotech Announces EMA Validation of Marketing Authorization Application for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa

PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization ...
Business Wire

Qihan Biotech Announces NMPA Approval of Investigational New Drug (IND) Application for QN-019a, a Multi-locus Gene-Editing Cell Therapy Product to treat CD19-positive B-Cell ...

HANGZHOU, China--(BUSINESS WIRE)--Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell ...
Business Wire

Legend Biotech Announces Submission of Supplemental Application to the U.S. FDA for Expanded Use of CARVYKTI ® (ciltacabtagene autoleucel)

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat ...
Business Insider

PDS Biotech to Host Key Opinion Leader Roundtable Addressing Current and Future Treatments for Recurrent/Metastatic HPV-Positive HNSCC and the Potential Application of PDS0101 ...

PRINCETON, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or Company), a clinical-stage immunotherapy company developing a growing pipeline of ...
FierceBiotech

GlaxoSmithKline announces new drug application and Phase III results for Rezonic/Zunrisa

GlaxoSmithKline (GSK) today announced the submission of a new drug application to the US Food and Drug Administration and new data from two Phase III trials for Rezonic TM /Zunrisa TM (casopitant), a ...
Seeking Alpha

FDA Accepts Krystal Biotech’s Biologics License Application for Dystrophic Epidermolysis Bullosa

FDA stated that it is not currently planning to hold an advisory committee meeting PITTSBURGH, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS), the leader ...